News Releases

Moffitt Cancer Center Named Best and Brightest Company to Work For in the Nation

This is the fourth year the cancer center has appeared on the list.

Moffitt Researchers Discover Mechanism that Regulates Anti-Tumor Activity of Immune Cells in Ovarian Cancer

IgA regulates immune cell activity by inhibiting RAS signaling and recognizing tumor markers

Moffitt Researchers Identify Why CAR T Therapy May Fail in Some Lymphoma Patients

Study finds immune dysregulation is associated with poor CAR T-cell expansion and resistance

Investigational Combo Therapy Shows Benefit for TP53 Mutant MDS and Acute Myeloid Leukemia Patients

Trial results show eprenetapopt plus azacitidine improves response

Spontaneous Cell Fusions Amplify Genetic Diversity Within Tumors, Moffitt Researchers Say

This allows them to adapt to new environments more quickly

Moffitt Researchers Identify How Cancer Cells Adapt to Survive Harsh Tumor Microenvironments

Activation of certain transcription factors allow cells to select for a Warburg phenotype

Dallas Cowboys Owner Jerry Jones Joins Moffitt Cancer Centers National Board of Advisors

Moffitt Researchers Discover Biochemical Pathway That Protects Cells from Ferroptosis Cell Death

Cysteine starvation results in GCLC-induced peptide accumulation

Paramount Pictures Futurist Joins Moffitt Cancer Center’s National Board of Advisors

Inflammation from Androgen Deprivation Therapy May Cause Fatigue in Prostate Cancer Patients

Moffitt Cancer Center study suggests elevation in inflammation marker IL-6 linked to higher levels of fatigue